Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Nov 14, 2019 4:19pm

117 Views

Post# 30352932

RE:IND mistery

Hey Georgie you should have gone further down in the wiki definition ... are you scared now!

Approximately two thirds of both INDs and new drug applications (NDAs) are small-molecule drugs. The rest are biopharmaceuticals. About half of the INDs fail in preclinical and clinical phases of drug development.

although it doesn't say in the wiki explanation should FDA ask for clarification that also resets the clock ... 30 days starts after the last communication

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario